Marinomed Biotech AG (MARI.VI)
EUR 13.0
(-1.89%)
EUR 13.0
(-1.89%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 21.79 Million EUR | -3.67% |
| 2022 | 22.62 Million EUR | 43.23% |
| 2021 | 15.79 Million EUR | 23.29% |
| 2020 | 12.81 Million EUR | 176.13% |
| 2019 | 4.64 Million EUR | -56.24% |
| 2018 | 10.6 Million EUR | -1.56% |
| 2017 | 10.77 Million EUR | 81.8% |
| 2016 | 5.92 Million EUR | 20.55% |
| 2015 | 4.91 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 21.74 Million EUR | -0.24% |
| 2023 Q4 | 21.79 Million EUR | 1.97% |
| 2023 Q2 | 21.55 Million EUR | -1.54% |
| 2023 Q3 | 21.37 Million EUR | -0.85% |
| 2023 Q1 | 21.89 Million EUR | -3.23% |
| 2023 FY | 21.79 Million EUR | -3.67% |
| 2022 FY | 22.62 Million EUR | 43.23% |
| 2022 Q4 | 22.62 Million EUR | -1.67% |
| 2022 Q3 | 23.01 Million EUR | 1.43% |
| 2022 Q2 | 22.68 Million EUR | 1.86% |
| 2022 Q1 | 22.27 Million EUR | 40.98% |
| 2021 FY | 15.79 Million EUR | 23.29% |
| 2021 Q2 | 13.22 Million EUR | 0.58% |
| 2021 Q4 | 15.79 Million EUR | 9.62% |
| 2021 Q3 | 14.41 Million EUR | 8.98% |
| 2021 Q1 | 13.14 Million EUR | 2.61% |
| 2020 Q3 | 4.97 Million EUR | 3.38% |
| 2020 Q2 | 4.8 Million EUR | 0.79% |
| 2020 Q1 | 4.77 Million EUR | 2.8% |
| 2020 FY | 12.81 Million EUR | 176.13% |
| 2020 Q4 | 12.81 Million EUR | 157.8% |
| 2019 FY | 4.64 Million EUR | -56.24% |
| 2019 Q4 | 4.64 Million EUR | 682.62% |
| 2019 Q3 | 592.94 Thousand EUR | -1.37% |
| 2019 Q2 | 601.15 Thousand EUR | -82.76% |
| 2019 Q1 | 3.48 Million EUR | -67.11% |
| 2018 Q4 | 10.6 Million EUR | -0.85% |
| 2018 FY | 10.6 Million EUR | -1.56% |
| 2018 Q3 | 10.69 Million EUR | 0.0% |
| 2017 Q4 | 10.77 Million EUR | 0.0% |
| 2017 FY | 10.77 Million EUR | 81.8% |
| 2016 FY | 5.92 Million EUR | 20.55% |
| 2015 FY | 4.91 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|